This month, the Australian federal government updated its website to state that Moderna's Spikevax is "no longer available" for children under 12.
It comes only three months after AstraZeneca's COVID-19 vaccine was discontinued in Australia. (The original Comirnaty [Pfizer] vaccines remain available for use for children under 12 in Australia.)
The updated website was inconspicuous; there was no press release, no media coverage, and no "dear doctor" letters.
A pediatric formulation of Moderna's mRNA vaccine was provisionally approved for children aged 6 years and older in February 2022 and for children aged 6 months to 5 years in July 2022.
But this only compounded earlier concerns about the safety of mRNA vaccines. The trials were small and there were no long-term safety data.
Myocarditis had been linked to the mRNA vaccines in young males — particularly from Moderna — with some postulating it was due to the higher concentrations of mRNA in Moderna's formulation.
It even prompted some governments, including Australia's Technical Advisory Group on Immunization, or ATAGI, to recommend extending the dosing interval from 4 weeks to 8 weeks, hoping to reduce the risk of myocarditis.
European countries like Denmark, Sweden, Germany, France and Norway, took it one step further and decided to suspend the use of Moderna's vaccine in young people because of safety concerns.
But is that why the Australian government says it's "no longer being manufactured" and therefore, "no longer available for use" in children under 12?
I asked direct questions to the Australian Therapeutic Goods Administration (TGA) about the safety data of Moderna's Spikevax vaccine. However, after weeks of enquires, I could not get a straight answer on the rate of serious adverse events (SAEs).
For example, initially, they quoted a very high SAE rate of "1 in 200" in clinical trial participants aged 6 months and <2 years — a rate that would far exceed the harms of COVID-19 infection — but then insisted it was "very rare."
When I sought clarity from the TGA, it began a string of emails back and forth, in which I would receive indirect responses to my direct questions about the rate of SAEs and its causal inference.
According to Moderna's Spikevax Fact Sheet (approved by the FDA), the clinical trial involving children aged 6 months to <2 years found SAEs were reported by 0.9% (n=15) of kids in the vaccine group versus 0.2% (n=1) in the placebo group.
But no mention was made of the nearly 5-fold increase (0.7% absolute difference) in SAEs between the vaccine and placebo group.
If the 0.7% absolute difference seen in the randomized trial reflects a real and accurate measure of the difference between groups, this would translate into a 1 in 147 rate of SAEs. (1 in 147 rate of SAEs based on calculation 1/(15/1761 [vaccine] - 1/589 [placebo)].)
Later in the document, however, it seems a value judgment was made (either by the regulator or Moderna) that only 1 of the 15 vaccinated children who reported an SAE, had an SAE that was actually caused by the vaccine.
It stated:
"In participants 6 months through 23 months of age who received the vaccine, a 1-year-old female experienced serious adverse events of a Grade 3 fever 6 hours after Dose 1 and a febrile convulsion 1 day after Dose 1. These events were considered related to vaccination."So, it is still not clear why the vaccine is no longer available and is no longer being manufactured for this age group.
Moderna is busy finishing its large-scale mRNA research and manufacturing facility in Melbourne, Victoria, which is expected to make 100 million mRNA doses each year, beginning in 2024.
Comment: Moderna is also busy 'building back better' elsewhere, such as in Montreal, Quebec with a new 100 million mRNA bio-pharma does factory. According to this from a year ago, Moderna is also rapidly expanding in the UK with an Innovation and Technology Center that has "rapid pandemic response capabilities" with a look to manufacturing at Oxfordshire. Stated, was that Africa is another destination, where they are also looking to six EU countries with the future aim for "subsidiaries in Hong Kong, Malaysia, Singapore and Taiwan."
That is just Moderna.
Pfizer's strategic portfolio currently looks like this:
Pfizer helps provide more than 50 billion doses of medicines and vaccines to over 181 countries annually, reaching approximately 1.3 billion patients — equivalent to 1 out of every 6 people on the planet.
Perhaps it was a business decision to stop manufacturing the vaccine for children under 12 because the uptake in that cohort has been so low.
Moderna did not respond to repeated inquiries.
Either way, the secrecy behind the safety data of COVID-19 vaccines in general, is only fuelling speculation and increasing distrust in vaccination more broadly.
Originally published on Maryanne Demasi's Substack page.
The views and opinions expressed in this article are those of the authors and do not necessarily reflect the views of Children's Health Defense.
Maryanne Demasi, Ph.D.
Maryanne Demasi, Ph.D. is an investigative medical reporter, speaker and TV presenter/producer.
.
"...Uptake of DoD biochemical weapons has been dropping, especially for the most recent ‘bivalent’ formulation, to whatever extent CDC data is considered reflective of real-world events.
This is the clearest sign, so far, that the American public — including people who walked into pharmacies and other points of dispensing and sat still for the first few injections — increasingly understands that infiltrators who have taken control of US government offices are actively engaged in a covert, biomedical-financial war against the American population.
The dropping ‘vaccination’ and ‘immunization’ rates are the clearest sign that a growing number of people are quietly refusing to volunteer themselves and their children as military targets for additional military attacks.
This is good news.
It matters a lot.
The globalist war machine — federal militaries merged with federal public health systems — is prepared to get more aggressive and use open armed force to attack people with needles if widespread enemy-civilian stubbornness forces their hands.
They’re prepared to offer another false choice, escalating from the first false choices of “take the injections or lose your job or place in school.”
The next false choices will be “take the injections or lose your access to banking transactions and your home” followed by “take the injections or go into a holding facility (hospital or separate DoD-HHS detention facility), where you will take the injection or take a bullet to the head.”But the globalist warmongers would really rather not see things get to that point.
They would prefer that the culling process continue to play out as quiet, calm, gradual, almost-invisible biomedical-financial violence, not loud, chaotic, visible, sudden gun violence.
They want sick and injured people dying more or less silently in their homes, with lots of plausible deniability as to injectable cause and lethal effect.
They don’t want healthy, mobile people dying loudly in the streets after being shot by readily identifiable, uniformed men and women using guns and bullets.
This is why it’s so important to refuse to comply.
Ordinary people refusing, every single hour of every single day, to walk into a pharmacy and take any more biochemical weapons voluntarily (setting aside the psychosocial and economic coercion used to obtain the first rounds of submission) are a major obstacle to the control-and-kill campaign proceeding as quietly as the globalists want it to be.
After individuals making personal decisions for themselves and their children, the next layer of noncompliance includes retail pharmacy owners and managers refusing to authorize their employees to take possession of DoD biochemical weapon deliveries, and pharmacists refusing to take the syringes and vials into their hands and push the poisons into enemy-civilian targets.
I don’t know if or when retail pharmacies will pull out of the Federal Retail Pharmacy Program, stop accepting DoD weapons shipments, and stop using the weapons to injure and kill people.
If and when the retail pharmacies start pulling out of the Federal Retail Pharmacy Program, those events will put more obstacles in the globalists’ path toward achieving one-world Satanic technocracy."